JSM2025
Back to all people

Gregory Goldmacher

Merck & Co., Inc.
1 appearance in the program

Sessions & presentations

SPEED 1: Data Challenge and Prediction Modelling, Part 1
Presentation: WITHDRAWN: Evaluating radiomics based predictors of survival under anti-PD1 therapy
Contributed Speed · Sun, Aug 3 , 2:00 PM
Co-Author
↑